Literature DB >> 12865386

Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents.

John Frean1, Keith P Klugman, Lorraine Arntzen, Stanley Bukofzer.   

Abstract

OBJECTIVES: To determine the susceptibility of southern African strains of Yersinia pestis to novel as well as conventional antimicrobial agents.
MATERIALS AND METHODS: The MICs of 28 strains of Yersinia pestis from a southern African plague focus were determined by agar dilution.
RESULTS: The most active agents were cefditoren and the fluoroquinolones, both conventional and novel. The in vitro activity of macrolides was poor against this member of the Enterobacteriaceae.
CONCLUSION: Further investigation of the novel quinolones olamufloxacin (HSR 903) and ABT 492 in animal models of plague would seem to be justified.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865386     DOI: 10.1093/jac/dkg363

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

Review 1.  Resistance of Yersinia pestis to antimicrobial agents.

Authors:  Marc Galimand; Elisabeth Carniel; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

2.  Multiplex PCR-ligation detection reaction assay for simultaneous detection of drug resistance and toxin genes from Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium.

Authors:  K Granger; M S Rundell; M R Pingle; R Shatsky; D H Larone; L M Golightly; F Barany; E D Spitzer
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

3.  Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis.

Authors:  David R Lonsway; Sandra K Urich; Henry S Heine; Sigrid K McAllister; Shailen N Banerjee; Martin E Schriefer; Jean B Patel
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

4.  In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods.

Authors:  Henry S Heine; Jeremy Hershfield; Charles Marchand; Lynda Miller; Stephanie Halasohoris; Bret K Purcell; Patricia L Worsham
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

5.  Lovastatin protects against experimental plague in mice.

Authors:  Saravanan Ayyadurai; Hubert Lepidi; Claude Nappez; Didier Raoult; Michel Drancourt
Journal:  PLoS One       Date:  2010-06-02       Impact factor: 3.240

6.  Rapid identification and antibiotic susceptibility testing of Yersinia pestis using bioluminescent reporter phage.

Authors:  David A Schofield; Ian J Molineux; Caroline Westwater
Journal:  J Microbiol Methods       Date:  2012-05-02       Impact factor: 2.363

7.  Phage-based platforms for the clinical detection of human bacterial pathogens.

Authors:  David A Schofield; Natasha J Sharp; Caroline Westwater
Journal:  Bacteriophage       Date:  2012-04-01

8.  Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.

Authors:  Nadine Lemaître; Xiaofei Liang; Javaria Najeeb; Chul-Jin Lee; Marie Titecat; Emmanuelle Leteurtre; Michel Simonet; Eric J Toone; Pei Zhou; Florent Sebbane
Journal:  MBio       Date:  2017-07-25       Impact factor: 7.867

Review 9.  Antibiotic Therapy of Plague: A Review.

Authors:  Florent Sebbane; Nadine Lemaître
Journal:  Biomolecules       Date:  2021-05-12

10.  Rapid Antibiotic Susceptibility Testing of Tier-1 Agents Bacillus anthracis, Yersinia pestis, and Francisella tularensis Directly From Whole Blood Samples.

Authors:  Shahar Rotem; Ohad Shifman; Moshe Aftalion; David Gur; Tamar Aminov; Ronit Aloni-Grinstein
Journal:  Front Microbiol       Date:  2021-07-09       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.